BPC-157 is not FDA-approved and was nominated for, then removed from, 503B bulk-compounding eligibility in 2024 based on FDA's safety review
For these men, after erections are addressed, we move on to treatment
Without adequate copper availability at the follicular level, newly synthesized collagen structures remain weak and fail to provide the structural support necessary for robust hair growth
J Affect Disord 48:14955
The problem is distribution
Challenge of Corneal Ulcer Healing: A Novel Conceptual Framework, the "Triad" of Corneal Ulcer Healing/Corneal Neovascularization/Intraocular Pressure, and Avascular Tendon Healing, for Evaluation of Corneal Ulcer Therapy, Therapy of Neovascularization, Glaucoma Therapy, and Pentadecapeptide BPC 157 Efficacy